InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.30
(
0.20%
)
Bitcoin
64,141.26
(
0.22%
)
Post# of 2804248
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ManicTrader

Send PM Follow Ignore
Followers 1324
Posts 66548
Boards Moderated 12
Alias Born 01/24/2010

ManicTrader

Re: ManicTrader post# 50609

Thursday, 06/02/2011 1:14:20 AM

Thursday, June 02, 2011 1:14:20 AM

Post# of 2804248
ANDS Anadys Pharma announces issuance of U.S. patent covering setrobuvir (ANA598) (1.20 -0.04)

Co announced issuance of the U.S. patent covering setrobuvir (ANA598), the Company's Direct-Acting Antiviral (DAA) in Phase IIb development for chronic hepatitis C virus infection (HCV). U.S. Patent No. 7,939,524, granted to Anadys by the United States Patent and Trademark Office, recognizes the Company's intellectual property rights to the composition of matter and methods of use for setrobuvir (ANA598) and related compounds.

LIKE 100-1000% GAINERS??

FOLLOW ME & STOCKGOODIES FOR MONSTER GAINS
http://investorshub.advfn.com/boards/board.aspx?board_id=18582
WINNERS OF 2010 IN IBOX

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up